Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- (-) Scheduling (national classification system) (5)
- (-) COVID-19 vaccines (2)
- Legislation (70)
- Listed medicines (38)
- Non-prescription medicines (32)
- Assessed listed medicines (20)
- Prescription medicines (20)
- Manufacturing (17)
- Advertising (16)
- Complementary medicines (16)
- Labelling and packaging (13)
- Therapeutic goods regulation (11)
- Over the counter (OTC) medicines (8)
- Regulatory compliance (8)
- Vaping hub (7)
- Australian Register of Therapeutic Goods (ARTG) (2)
- COVID-19 (2)
- In Vitro Diagnostic medical devices (IVDs) (2)
- Biological medicines (1)
- Blood and blood components (1)
- Clinical trials (1)
- Import and export (1)
- Sunscreens (1)
Search
7 result(s) found, displaying 1 to 7
-
NoticesThis instrument is made under section 39 of the current Poisons Standard.
-
NoticesThis instrument is made under section 39 of the current Poisons Standard.
-
NoticesWe are providing a 12-month period of labelling exemptions for signal words for certain Pharmacy medicine and Pharmacist Only medicine products.
-
NoticesThis instrument is the Therapeutic Goods (Poisons Standard) (Benzylpenicillin—Seqirus) Approval 2024.
-
NoticesWe've granted a labelling exemption for the COVID-19 Vaccine, Pfizer (raxtozinameran), under the current Poisons Standard.
-
NoticesThis instrument is made under section 39 of the current Poisons Standard.
-
NoticesThis labelling exemption is granted under section 1.1(3) of Part 2 of the current Poisons Standard.